aiqbench analysis

Albert has secured $55 million in Series B funding to expand its chemistry-native artificial intelligence platform, which aims to accelerate material discovery and chemical synthesis. This capital injection will enable the company to scale its proprietary models that directly integrate quantum mechanical principles with deep learning for drug development and materials science. The move underscores growing investor confidence in AI applications specifically tailored to complex scientific domains rather than general-purpose language or image tasks.